The First Hypervariable Region of the gp120 Env Glycoprotein Defines the Neutralizing Susceptibility of Heterologous Human Immunodeficiency Virus Type 1 Isolates to Neutralizing Antibodies Elicited by the SF162gp140 Immunogen

Current vaccine efforts to elicit cross-reactive neutralizing antibodies (NAbs) against human immunodeficiency virus (HIV) focus on the engineering of soluble mimetics of the trimeric HIV Env glycoprotein (commonly termed gp140 immunogens). Such immunogens are thought to be more effective than previ...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Ching, Lance K., Vlachogiannis, Giorgos, Bosch, Katherine A., Stamatatos, Leonidas
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology (ASM) 2008
Aiheet:
Pathogenesis and Immunity
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2224580/
https://ncbi.nlm.nih.gov/pubmed/18003732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.02143-07
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia